<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ph-positive <z:hpo ids='HP_0004808'>acute myeloblastic leukemia</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>) developing in a treated case of Wegener's <z:hpo ids='HP_0002955'>granulomatosis</z:hpo> is reported </plain></SENT>
<SENT sid="1" pm="."><plain>The patient was a 70-year-old white male who received <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (150 mg/day) starting in July 1978; in May 1984 the patient was diagnosed as having <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>, following a diagnosis of <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> lasting 3 months </plain></SENT>
<SENT sid="2" pm="."><plain>Cytogenetic study of bone marrow cells at the diagnosis of the <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> revealed a standard Ph translocation in addition to numerical chromosome changes [i.e., 45,XY, -5, -7, -8, +19, +mar/45,XY, -5, -7, -8, +19, +mar,t(9;22)(q34;q11]) </plain></SENT>
<SENT sid="3" pm="."><plain>The events in this case suggest a strong possibility of the Ph-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e> being a <z:e sem="disease" ids="C0277555" disease_type="Disease or Syndrome" abbrv="">secondary disease</z:e> related to prior <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> therapy </plain></SENT>
</text></document>